Kim Clark-Langone

Kim Clark-Langone has over two decades of experience in the biotechnology industry. Most recently, they worked at Fellow as SVP R&D in 2023. Prior to this, they were a member at Chief in 2022. Kim was also the VP of New Product Development and New Technology Development at CareDx, Inc. from 2021 to 2023. Before that, they served as Senior Director of Assay Development at Talis Biomedical Corporation (2020-2021) and Senior Director of Assay & Informatics Development at Exact Sciences (2020). Kim has extensive experience with Genomic Health, where they began working in 2001. Their first role at the company was as a Research Scientist I/II, and they worked their way up to Staff Scientist and Senior Development Scientist I and II. Kim also held Director and Senior Director positions in Product Science. Kim was responsible for leading various successful projects related to Oncotype DX, including the Colon Cancer Assay and SEQ Liquid Select. Kim has a Ph.D. in Biological Sciences from Stanford University, where they were a Postdoctoral Researcher from 1999 to 2001.

Kim Clark-Langone has a Bachelor's degree in Genetics from Newcastle University and a PhD in Mitochondrial Genetics from the same institution. Kim also completed a postdoc at Stanford University, but the field of study is unspecified.